Please assess the completion status of the following clinical trial:

Trial Title: Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18 to 65 years~* Willingness and ability to provide informed consent~* Have an active email address and internet access~* Physical exam in the last 12 months with the following documented evaluations in EMR (Electronic Medical record):~  1. Blood pressure~ 2. Height and weight~ 3. Fasting blood glucose or Hemoglobin A1C (HbA1c)~ 4. Lipid panel (TC, LDL, HDL, TRIG) with at least one of them outside of the normal ranges defined as:~  i.BMI ≥ 25 kg/m2 (BMI = weight \[kg\] / ht \[m\]2)~ii.FPG \> 100 AND ≤ 125 mg/dL~iii.HbA1c \> 5.7% ≤ 6.4%~iv.SBP ≥ 130 mmHg~v.TC ≥ 200 mg/dL~vi.TRIG ≥ 150 mg/dL~vii.LDL ≥ 129 mg/dL~Exclusion Criteria:~* Projected deployment in the upcoming 6 months~* Diagnosed type 2 diabetes~* Diagnosed coronary heart disease (CHD) -(Myocardial Infarction, or documented CHD)~* Inability to ambulate or participate in physical activity~* Serious chronic disease related complications or conditions that could significantly affect study outcomes \[currently treated cancer, renal failure, cardiovascular accident (CVA) with residual effects on functioning~* Current participation in another research study~* Spouse, partner or other household member already participating in this study protocol

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: t

Study Arms:
- Standard Risk Assessment (SRA) (Type: ACTIVE_COMPARATOR): Subjects will receive a standard risk assessment only for coronary heart disease (CHD) and type 2 diabetes (T2D). Standard risk factors are reviewed by a provider at a risk counseling visit with the subject.
- SRA plus Health Coaching (HC) (Type: EXPERIMENTAL): In addition to the standard risk assessment for CHD and T2D subjects will receive health coaching intervention for 6 months
- SRA plus Genetic Risk Counseling (GRC) (Type: EXPERIMENTAL): In addition to the SRA subjects will receive genetic risk counseling at the risk counseling visit with a clinic provider. Genetic test results for CHD (rs10757274) and T2D (rs7903146, rs1801282, rs5219) risk variants will be incorporated into the risk profile reviewed with subjects.
- SRA+HC+GRC (Type: EXPERIMENTAL): In addition to the standard risk assessment for CHD and T2D subjects will receive genetic risk counseling and health coaching intervention for 6 months.

Based on this trial design, predict the completion outcome and termination type (if applicable).